Diabetes After Menopause: Heart and Bone Health

Perimenopause is loud. Readings wander, flushes arrive, sleep breaks up, and it is obvious that something has changed. What comes after is quiet. The hormone swings stop, blood sugar settles into a new rhythm, and most women stop thinking about menopause altogether.

That quiet is worth interrupting once. Two things shift permanently in the postmenopausal years, neither of them announces itself, and both are things you can actually do something about if you know to ask. This article is about those two — heart and bone. If you are still in the middle of the change and your numbers have stopped making sense, the companion piece on [menopause and blood sugar](/blog/menopause-and-blood-sugar-what-changes-and-why) is the one to read first.

What settled, and what didn't

After the transition, oestrogen stops fluctuating — but it stops at a low level, and the body it leaves behind is a different one. Fat tends to redistribute toward the abdomen, muscle mass drops, and cholesterol shifts in an unhelpful direction.

The important detail is that this is not simply ageing. The American Heart Association's 2020 scientific statement (opens in a new tab) on the menopause transition (MT) reviewed twenty years of studies that followed the same women across the change, which allowed researchers to separate the effect of getting older from the effect of the transition itself. The adverse changes in body composition, lipids and vascular health tracked the transition:

“The reported findings underline the significance of the MT as a time of accelerating CVD risk, thereby emphasizing the importance of monitoring women's health during midlife, a critical window for implementing early intervention strategies to reduce CVD risk.”

For a woman with diabetes, that means the postmenopausal baseline usually needs different doses, and often different attention, than the premenopausal one did — not because anything went wrong, but because the underlying conditions changed.

The heart advantage you had is gone

Before menopause, women generally develop heart disease later than men do. After menopause that gap narrows. And diabetes closes it faster in women than in men — this is one of the more consistent findings in the field, and it is not widely known.

A meta-analysis of 64 cohorts published in Diabetologia (opens in a new tab), covering 858,507 people and 28,203 coronary events, found that diabetes raised the risk of coronary heart disease about 2.8-fold in women and about 2.2-fold in men. Put side by side, the relative risk was 44% greater in women with diabetes than in men with diabetes.

This is not a reason to feel doomed, and it does not mean heart disease is coming for you. It means the things that protect the heart — blood pressure control, cholesterol, not smoking, movement — earn more for a woman with diabetes than the general advice implies. If your blood pressure and lipid profile have not been checked in the last year, that is the concrete thing to fix. Our guide on [diabetes and heart health](/blog/diabetes-and-heart-health-cardiovascular-disease) covers what those numbers mean.

Bone: the result that looks reassuring and isn't

This is the part almost nobody is told. Menopause itself accelerates bone loss. Type 2 diabetes adds to fracture risk on top of that — but it does so without lowering the number on a bone density scan.

A meta-analysis in Osteoporosis International (opens in a new tab) laid the contradiction out clearly. In type 2 diabetes, hip fracture risk was about 38% higher than in people without diabetes. Yet bone mineral density in type 2 diabetes averaged slightly higher than that of people the same age, at both the spine and the hip. Higher density, more fractures. The likely explanation is bone quality rather than quantity: the bone is dense but structurally poorer, and years of high glucose appear to be part of why.

The American Diabetes Association's Standards of Care (opens in a new tab) now treat this as routine business rather than a specialist concern. They advise assessing fracture risk in older adults with diabetes as part of ordinary diabetes care, and monitoring bone density by DXA scan every two to three years in those aged 65 and over — and in younger people with diabetes who carry multiple risk factors.

Two of their other recommendations are worth knowing because they may change what is in your pill box. The Standards advise weighing the effect on bone when choosing glucose-lowering medicines, and avoiding ones linked to higher fracture risk — thiazolidinediones such as pioglitazone, and sulfonylureas — in people whose fracture risk is already raised. They also advise favouring medicines with a low risk of hypoglycemia in this group, for a very practical reason: a low that causes a fall is how a fracture actually happens.

That last point deserves its own sentence. In older women, the danger of a hypo is often not the hypo. It is the floor.

In Pakistan, bone health starts from further behind

Diabetes is not the only thing working against bone here. A study of 140 postmenopausal women in rural Pakistan (opens in a new tab) screened bone using an ultrasound measure and found 42% in the osteopenia range and 29% in the osteoporosis range. Average daily calcium intake was 346 mg — less than half the recommended amount. Vitamin D levels tracked with bone quality even after accounting for age.

This matters because it is fixable and cheap. The ADA Standards suggest a daily calcium intake of 1,000 to 1,200 mg for people at fracture risk, alongside adequate vitamin D. Dahi and lassi, milk, paneer, sesame (til), and green leafy vegetables like saag and methi all contribute meaningfully. Sunlight helps with vitamin D, though a woman who is largely indoors, or fully covered outdoors, may not get enough from it — which is a reasonable thing to test for rather than guess at.

What to raise at your next appointment

None of this requires a new specialist. It is a handful of questions at a visit you were already going to have.

• "When were my blood pressure and lipids last done?" Both shift after menopause, and both carry more weight for a woman with diabetes.
• "Should I have a bone density scan?" Especially if you are 65 or over, or younger with several risk factors — long diabetes duration, insulin use, previous fracture, frequent falls.
• "Do any of my current medicines affect my bones?" A short, fair question if you are on pioglitazone or a sulfonylurea.
• "Am I having lows I am not noticing?" Falls and fractures usually trace back here.
• "Should my vitamin D be checked?" Deficiency is common in Pakistani women and easy to correct once it is on paper.

One more: strength. Resistance work — even light weights, resistance bands, or sitting-to-standing repetitions at home — improves insulin sensitivity and loads bone at the same time. It is the rare intervention that addresses both of the things this article is about, and it costs nothing.

Bring numbers, not impressions

Appointments go better when you can show a pattern instead of describing one. Logging your readings — and noting the days you felt shaky, dizzy or unsteady — turns a vague worry about lows into something your doctor can act on.

Start logging with Diatic (opens Diatic on Google Play in a new tab)